Clinical trial
Galantamine in the Treatment of Post-Traumatic Headache
NCT00219869 · Rapoport, Alan, M.D., Other · Unknown status
Key facts
| NCT number | NCT00219869 |
|---|---|
| Title | Galantamine in the Treatment of Post-Traumatic Headache |
| Official title | Galantamine in the Preventive Treatment of Chronic Post-Traumatic Headache |
| Lead sponsor | Rapoport, Alan, M.D., Other |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Post-Traumatic Headache, Head Trauma, Closed, Retention Disorders, Cognitive |
| Intervention type | Drug |
| Interventions | Galantamine |
| Enrollment | 30 |
| Start date | Jul 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: